$76.78
5.55%
NYSE, Sep 18, 04:00 pm EDT. Closed.
Why the stock moved Why the stock moved Beta
ISIN
US4577301090
Symbol
INSP

Inspire Medical Systems, Inc. Target price 2026 - Analyst rating & recommendation

Inspire Medical Systems, Inc. Classifications & Recommendation

Buy
38%
Hold
54%
Sell
8%

Inspire Medical Systems, Inc. Price Target

Target Price $61.20
Price $76.78
Deviation
Number of Estimates 19
19 Analysts have issued a price target Inspire Medical Systems, Inc. 2027 . The average Inspire Medical Systems, Inc. target price is $61.20. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 24 analysts: 9 Analysts recommend Inspire Medical Systems, Inc. to buy, 13 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Inspire Medical Systems, Inc. stock has an average upside potential 2027 of . Most analysts recommend the Inspire Medical Systems, Inc. stock at Hold.

Sales and Margin forecast 2026, 2027 to 2031

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 911.98 868.53
13.60% 4.76%
EBITDA Margin 7.12% 21.77%
34.04% 205.87%
Net Margin 15.95% 1.06%
139.23% 93.35%

20 Analysts have issued a sales forecast Inspire Medical Systems, Inc. 2026 . The average Inspire Medical Systems, Inc. sales estimate is

$869m
unlock
. This is
3.36% lower
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$905m 0.70%
unlock
, the lowest is
$809m 9.93%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $912m 13.60%
2026
$869m 4.76%
unlock
2027
$902m 3.83%
unlock
2028
$962m 6.69%
unlock
2029
$1.1b 15.37%
unlock
2030
$1.2b 10.18%
unlock
2031
$1.3b 6.38%
unlock

17 Analysts have issued an Inspire Medical Systems, Inc. EBITDA forecast 2026. The average Inspire Medical Systems, Inc. EBITDA estimate is

$189m
unlock
. This is
165.05% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$215m 201.49%
unlock
, the lowest is
$166m 132.19%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $64.9m 52.26%
2026
$189m 191.26%
unlock
2027
$207m 9.60%
unlock
2028
$214m 3.43%
unlock
2029
$219m 2.32%
unlock
2030
$256m 16.74%
unlock
2031
$461m 80.08%
unlock

EBITDA Margin

2025 7.12% 34.04%
2026
21.77% 205.87%
unlock
2027
22.98% 5.56%
unlock
2028
22.28% 3.05%
unlock
2029
19.76% 11.31%
unlock
2030
20.93% 5.92%
unlock

19 Inspire Medical Systems, Inc. Analysts have issued a net profit forecast 2026. The average Inspire Medical Systems, Inc. net profit estimate is

$9.2m
unlock
. This is
93.16% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$38.6m 71.45%
unlock
, the lowest is
$-7.1m 105.24%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $145m 171.76%
2026
$9.2m 93.65%
unlock
2027
$41.2m 345.89%
unlock
2028
$59.0m 43.08%
unlock
2029
$84.0m 42.56%
unlock
2030
$111m 32.28%
unlock
2031
$117m 5.31%
unlock

Net Margin

2025 15.95% 139.23%
2026
1.06% 93.35%
unlock
2027
4.57% 331.13%
unlock
2028
6.13% 34.14%
unlock
2029
7.57% 23.49%
unlock
2030
9.09% 20.08%
unlock
2031
9.00% 0.99%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2031

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 4.89 0.32
179.43% 93.46%
P/E 240.24
EV/Sales 2.19

19 Analysts have issued a Inspire Medical Systems, Inc. forecast for earnings per share. The average Inspire Medical Systems, Inc. EPS is

$0.32
unlock
. This is
93.13% lower
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$1.33 71.46%
unlock
, the lowest is
$-0.25 105.36%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $4.89 179.43%
2026
$0.32 93.46%
unlock
2027
$1.43 346.88%
unlock
2028
$2.04 42.66%
unlock
2029
$2.91 42.65%
unlock
2030
$3.85 32.30%
unlock
2031
$4.05 5.19%
unlock

P/E ratio

Current 16.48 62.95%
2026
240.24 1,358.09%
unlock
2027
53.88 77.57%
unlock
2028
37.65 30.12%
unlock
2029
26.41 29.85%
unlock
2030
19.97 24.38%
unlock
2031
18.96 5.06%
unlock

Based on analysts' sales estimates for 2026, the Inspire Medical Systems, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.11 12.08%
2026
2.19 3.63%
unlock
2027
2.11 3.69%
unlock
2028
1.97 6.27%
unlock
2029
1.71 13.32%
unlock
2030
1.55 9.24%
unlock
2031
1.46 6.00%
unlock

P/S ratio

Current 2.47 10.14%
2026
2.56 3.48%
unlock
2027
2.46 3.69%
unlock
2028
2.31 6.27%
unlock
2029
2.00 13.32%
unlock
2030
1.82 9.24%
unlock
2031
1.71 5.99%
unlock

Current Inspire Medical Systems, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Stifel
Locked
Locked
Locked Sep 11 2026
Evercore ISI Group
Locked
Locked
Locked Aug 04 2026
JP Morgan
Locked
Locked
Locked Aug 04 2026
Piper Sandler
Locked
Locked
Locked Aug 04 2026
Mizuho
Locked
Locked
Locked Aug 04 2026
Oppenheimer
Locked
Locked
Locked Aug 04 2026
Baird
Locked
Locked
Locked Aug 04 2026
Analyst Rating Date
Locked
Stifel:
Locked
Locked
Sep 11 2026
Locked
Evercore ISI Group:
Locked
Locked
Aug 04 2026
Locked
JP Morgan:
Locked
Locked
Aug 04 2026
Locked
Piper Sandler:
Locked
Locked
Aug 04 2026
Locked
Mizuho:
Locked
Locked
Aug 04 2026
Locked
Oppenheimer:
Locked
Locked
Aug 04 2026
Locked
Baird:
Locked
Locked
Aug 04 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today